Medplus Health Services Limited - Asset Resilience Ratio

Latest as of September 2025: 8.18%

Medplus Health Services Limited (MEDPLUS) has an Asset Resilience Ratio of 8.18% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Medplus Health Services Limited debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

Rs2.92 Billion
≈ $31.59 Million USD Cash + Short-term Investments

Total Assets

Rs35.72 Billion
≈ $386.32 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how Medplus Health Services Limited's Asset Resilience Ratio has changed over time. See Medplus Health Services Limited book value and equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Medplus Health Services Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see MEDPLUS company net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rs0.00 0%
Short-term Investments Rs2.92 Billion 8.18%
Total Liquid Assets Rs2.92 Billion 8.18%

Asset Resilience Insights

  • Limited Liquidity: Medplus Health Services Limited maintains only 8.18% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Medplus Health Services Limited Industry Peers by Asset Resilience Ratio

Compare Medplus Health Services Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Corporativo Fragua S.A.B. de C.V
MX:FRAGUAB
Pharmaceutical Retailers 0.43%
High Tide Inc
V:HITI
Pharmaceutical Retailers 0.03%
Raia Drogasil S.A
SA:RADL3
Pharmaceutical Retailers 0.08%
Empreendimentos Pague Menos S.A
SA:PGMN3
Pharmaceutical Retailers 0.88%
d1000 Varejo Farma Participações S.A
SA:DMVF3
Pharmaceutical Retailers 0.59%
Yifeng Pharmacy
SHG:603939
Pharmaceutical Retailers 19.16%
Laobaixing Pharmacy
SHG:603883
Pharmaceutical Retailers 0.01%
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
SHE:301408
Pharmaceutical Retailers 0.94%

Annual Asset Resilience Ratio for Medplus Health Services Limited (2019–2025)

The table below shows the annual Asset Resilience Ratio data for Medplus Health Services Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 10.53% Rs3.54 Billion
≈ $38.26 Million
Rs33.60 Billion
≈ $363.38 Million
+8.07pp
2024-03-31 2.46% Rs738.26 Million
≈ $7.98 Million
Rs30.05 Billion
≈ $324.96 Million
+0.30pp
2023-03-31 2.16% Rs602.99 Million
≈ $6.52 Million
Rs27.97 Billion
≈ $302.45 Million
-22.37pp
2022-03-31 24.52% Rs6.36 Billion
≈ $68.79 Million
Rs25.94 Billion
≈ $280.54 Million
+21.82pp
2021-03-31 2.70% Rs423.16 Million
≈ $4.58 Million
Rs15.66 Billion
≈ $169.32 Million
+0.70pp
2020-03-31 2.00% Rs270.30 Million
≈ $2.92 Million
Rs13.49 Billion
≈ $145.86 Million
-0.59pp
2019-03-31 2.59% Rs248.24 Million
≈ $2.68 Million
Rs9.59 Billion
≈ $103.68 Million
--
pp = percentage points

About Medplus Health Services Limited

NSE:MEDPLUS India Pharmaceutical Retailers
Market Cap
$1.13 Billion
Rs104.66 Billion INR
Market Cap Rank
#8584 Global
#408 in India
Share Price
Rs872.15
Change (1 day)
-0.96%
52-Week Range
Rs741.80 - Rs977.20
All Time High
Rs1290.00
About

MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, such as prescription medicines, over-the-counter drugs, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soap… Read more